The ‘silencing effect’ exerted by extremely inactivating PSEN1 variants, not only argues against a simple GSEC loss-of-function mechanism, but also supports the selective targeting of the pathogenic allele as a potential therapeutic approach in FAD. Here, PSEN1 is linked to familial Alzheimer disease.